Chief Financial Officer · RECURSION PHARMACEUTICALS, INC. · Class A Common Stock
Side
F
Value
$149K
Shares
48.0K
Price
$3.11
Executed
Apr 6, 2026
Disclosed
Apr 8, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 6 executedApr 8, 2026 disclosed
RXRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+4 / 25
$149K reported value · 4.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Taylor Ben R filed this Form 4 reporting a tax withholding of RXRX on Apr 6, 2026. It became public on Apr 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Taylor Ben Rcik:0001712276
Issuer
RECURSION PHARMACEUTICALS, INC.cik:0001601830
Revision history · 0
No field has changed since this record was first ingested.
